Author:
Jacobson D M,Lewis J H,Bontempo F A,Spero J A,Ragni M V,Reinmuth O M
Abstract
Inhibitors blocking coagulation reactions, often called lupus anticoagulants, are readily identifiable but rarely considered as risk factors for cerebral infarction. These inhibitors are inconsistently found in a number of diseases (often autoimmune) and after treatment with ceretain drugs and appear to be closely associated with, or identical to, antibodies to certain phospholipids. We have observed two brothers with these inhibitors who both experienced recurrent cerebral infarctions. Such familial occurrence has rarely been reported. In addition, some other family members were found to have depressed factor XII levels. Using the technique of double immunodiffusion, we found that the serum from these brothers formed precipitin lines against certain phospholipid substrates, lending further support to the antiphospholipid nature of this inhibitor.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Advanced and Specialised Nursing,Cardiology and Cardiovascular Medicine,Clinical Neurology
Reference36 articles.
1. Acquired inhibitors of blood coagulation;Femstein DI;Prog Hemostas Thromb,1972
2. A clinical study of the Iupus anticoagulant;Schleider MA;Blood,1976
3. The lupus anticoagulant
4. Shoenfeld Y Schwartz RS. Immunologic and genetic factors in autoimmune disease N Engl J Med 311: 1019-1029 1984
5. A hemorrhagic disorder caused by circulating anticoagulant in patients with disseminated Iupus erythematosus;Conley CL;J Clin Invest,1952
Cited by
30 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献